Mean ± SD of baseline characteristics of the 191 study subjects by the VDR FokI genotype
Variable . | VDR FokI genotype . | . | . | P a . | ||
---|---|---|---|---|---|---|
. | FF . | Ff . | ff . | . | ||
No. of subjects (%) | 78 (41%) | 73 (38%) | 40 (21%) | |||
Age at surgery (yrs) | 64.8 ± 6.8 | 65.2 ± 6.5 | 63.2 ± 6.2 | 0.28 | ||
% Gleason grade 4/5 | 42.8 ± 30.0 | 43.8 ± 30.2 | 30.3 ± 28.6 | 0.05b | ||
Index cancer volume (cc) | 5.2 ± 5.3 | 5.3 ± 5.7 | 5.7 ± 6.0 | 0.88 | ||
Preoperative serum PSA (ng/ml) | 24.5 ± 39.5 | 19.7 ± 23.2 | 18.5 ± 14.1 | 0.49 |
Variable . | VDR FokI genotype . | . | . | P a . | ||
---|---|---|---|---|---|---|
. | FF . | Ff . | ff . | . | ||
No. of subjects (%) | 78 (41%) | 73 (38%) | 40 (21%) | |||
Age at surgery (yrs) | 64.8 ± 6.8 | 65.2 ± 6.5 | 63.2 ± 6.2 | 0.28 | ||
% Gleason grade 4/5 | 42.8 ± 30.0 | 43.8 ± 30.2 | 30.3 ± 28.6 | 0.05b | ||
Index cancer volume (cc) | 5.2 ± 5.3 | 5.3 ± 5.7 | 5.7 ± 6.0 | 0.88 | ||
Preoperative serum PSA (ng/ml) | 24.5 ± 39.5 | 19.7 ± 23.2 | 18.5 ± 14.1 | 0.49 |